ST步森(002569.SZ):終止前次定增事項並重新籌劃2021年度非公開發行A股股票事項
格隆匯8月18日丨ST步森(002569.SZ)公佈,此前披露,公司擬非公開發行A股股票,發行對象為公司實際控制人王春江控制的企業浙江瀚漫科技有限責任公司,發行數量為不超過4300萬股(含本數),募集資金總額不超過2.83億元(含本數)。
鑑於自籌劃該次非公開發行股票以來,資本市場環境、融資時機等因素髮生了諸多變化,綜合考慮公司整體經營規劃,公司決定終止該次非公開發行A股股票事項。提出新的非公開發行A股股票預案。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.